TrialInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022

Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial.

Els Tobback et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.